Depression

Ketamine used in patients with treatment-resistant depression operates via serotonin 1B receptors by way of a previously unknown mechanism of action, according to a new study from Sweden.

Analysis of EEG data from patients with major depressive disorder predicted response to SSRI treatment with accuracy of nearly 80%, according to a new study.

Highlights from a recent evidence-based review offer guidance on feasible depression treatments in primary care.